Cargando…

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

In this multi-institutional study we compiled a retrospective cohort of 86 posterior fossa tumors having received the diagnosis of cerebellar glioblastoma (cGBM). All tumors were reviewed histologically and subjected to array-based methylation analysis followed by algorithm-based classification into...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhardt, Annekathrin, Stichel, Damian, Schrimpf, Daniel, Koelsche, Christian, Wefers, Annika K., Ebrahimi, Azadeh, Sievers, Philipp, Huang, Kristin, Casalini, M. Belén, Fernández-Klett, Francisco, Suwala, Abigail, Weller, Michael, Gramatzki, Dorothee, Felsberg, Joerg, Reifenberger, Guido, Becker, Albert, Hans, Volkmar H., Prinz, Marco, Staszewski, Ori, Acker, Till, Dohmen, Hildegard, Hartmann, Christian, Paulus, Werner, Heß, Katharina, Brokinkel, Benjamin, Schittenhelm, Jens, Buslei, Rolf, Deckert, Martina, Mawrin, Christian, Hewer, Ekkehard, Pohl, Ute, Jaunmuktane, Zane, Brandner, Sebastian, Unterberg, Andreas, Hänggi, Daniel, Platten, Michael, Pfister, Stefan M., Wick, Wolfgang, Herold-Mende, Christel, Korshunov, Andrey, Reuss, David E., Sahm, Felix, Jones, David T. W., Capper, David, von Deimling, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816155/
https://www.ncbi.nlm.nih.gov/pubmed/31661039
http://dx.doi.org/10.1186/s40478-019-0801-8
_version_ 1783463326507859968
author Reinhardt, Annekathrin
Stichel, Damian
Schrimpf, Daniel
Koelsche, Christian
Wefers, Annika K.
Ebrahimi, Azadeh
Sievers, Philipp
Huang, Kristin
Casalini, M. Belén
Fernández-Klett, Francisco
Suwala, Abigail
Weller, Michael
Gramatzki, Dorothee
Felsberg, Joerg
Reifenberger, Guido
Becker, Albert
Hans, Volkmar H.
Prinz, Marco
Staszewski, Ori
Acker, Till
Dohmen, Hildegard
Hartmann, Christian
Paulus, Werner
Heß, Katharina
Brokinkel, Benjamin
Schittenhelm, Jens
Buslei, Rolf
Deckert, Martina
Mawrin, Christian
Hewer, Ekkehard
Pohl, Ute
Jaunmuktane, Zane
Brandner, Sebastian
Unterberg, Andreas
Hänggi, Daniel
Platten, Michael
Pfister, Stefan M.
Wick, Wolfgang
Herold-Mende, Christel
Korshunov, Andrey
Reuss, David E.
Sahm, Felix
Jones, David T. W.
Capper, David
von Deimling, Andreas
author_facet Reinhardt, Annekathrin
Stichel, Damian
Schrimpf, Daniel
Koelsche, Christian
Wefers, Annika K.
Ebrahimi, Azadeh
Sievers, Philipp
Huang, Kristin
Casalini, M. Belén
Fernández-Klett, Francisco
Suwala, Abigail
Weller, Michael
Gramatzki, Dorothee
Felsberg, Joerg
Reifenberger, Guido
Becker, Albert
Hans, Volkmar H.
Prinz, Marco
Staszewski, Ori
Acker, Till
Dohmen, Hildegard
Hartmann, Christian
Paulus, Werner
Heß, Katharina
Brokinkel, Benjamin
Schittenhelm, Jens
Buslei, Rolf
Deckert, Martina
Mawrin, Christian
Hewer, Ekkehard
Pohl, Ute
Jaunmuktane, Zane
Brandner, Sebastian
Unterberg, Andreas
Hänggi, Daniel
Platten, Michael
Pfister, Stefan M.
Wick, Wolfgang
Herold-Mende, Christel
Korshunov, Andrey
Reuss, David E.
Sahm, Felix
Jones, David T. W.
Capper, David
von Deimling, Andreas
author_sort Reinhardt, Annekathrin
collection PubMed
description In this multi-institutional study we compiled a retrospective cohort of 86 posterior fossa tumors having received the diagnosis of cerebellar glioblastoma (cGBM). All tumors were reviewed histologically and subjected to array-based methylation analysis followed by algorithm-based classification into distinct methylation classes (MCs). The single MC containing the largest proportion of 25 tumors diagnosed as cGBM was MC anaplastic astrocytoma with piloid features representing a recently-described molecular tumor entity not yet included in the WHO Classification of Tumours of the Central Nervous System (WHO classification). Twenty-nine tumors molecularly corresponded to either of 6 methylation subclasses subsumed in the MC family GBM IDH wildtype. Further we identified 6 tumors belonging to the MC diffuse midline glioma H3 K27 M mutant and 6 tumors allotted to the MC IDH mutant glioma subclass astrocytoma. Two tumors were classified as MC pilocytic astrocytoma of the posterior fossa, one as MC CNS high grade neuroepithelial tumor with BCOR alteration and one as MC control tissue, inflammatory tumor microenvironment. The methylation profiles of 16 tumors could not clearly be assigned to one distinct MC. In comparison to supratentorial localization, the MC GBM IDH wildtype subclass midline was overrepresented, whereas the MCs GBM IDH wildtype subclass mesenchymal and subclass RTK II were underrepresented in the cerebellum. Based on the integration of molecular and histological findings all tumors received an integrated diagnosis in line with the WHO classification 2016. In conclusion, cGBM does not represent a molecularly uniform tumor entity, but rather comprises different brain tumor entities with diverse prognosis and therapeutic options. Distinction of these molecular tumor classes requires molecular analysis. More than 30% of tumors diagnosed as cGBM belong to the recently described molecular entity of anaplastic astrocytoma with piloid features. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0801-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6816155
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68161552019-10-31 Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities Reinhardt, Annekathrin Stichel, Damian Schrimpf, Daniel Koelsche, Christian Wefers, Annika K. Ebrahimi, Azadeh Sievers, Philipp Huang, Kristin Casalini, M. Belén Fernández-Klett, Francisco Suwala, Abigail Weller, Michael Gramatzki, Dorothee Felsberg, Joerg Reifenberger, Guido Becker, Albert Hans, Volkmar H. Prinz, Marco Staszewski, Ori Acker, Till Dohmen, Hildegard Hartmann, Christian Paulus, Werner Heß, Katharina Brokinkel, Benjamin Schittenhelm, Jens Buslei, Rolf Deckert, Martina Mawrin, Christian Hewer, Ekkehard Pohl, Ute Jaunmuktane, Zane Brandner, Sebastian Unterberg, Andreas Hänggi, Daniel Platten, Michael Pfister, Stefan M. Wick, Wolfgang Herold-Mende, Christel Korshunov, Andrey Reuss, David E. Sahm, Felix Jones, David T. W. Capper, David von Deimling, Andreas Acta Neuropathol Commun Research In this multi-institutional study we compiled a retrospective cohort of 86 posterior fossa tumors having received the diagnosis of cerebellar glioblastoma (cGBM). All tumors were reviewed histologically and subjected to array-based methylation analysis followed by algorithm-based classification into distinct methylation classes (MCs). The single MC containing the largest proportion of 25 tumors diagnosed as cGBM was MC anaplastic astrocytoma with piloid features representing a recently-described molecular tumor entity not yet included in the WHO Classification of Tumours of the Central Nervous System (WHO classification). Twenty-nine tumors molecularly corresponded to either of 6 methylation subclasses subsumed in the MC family GBM IDH wildtype. Further we identified 6 tumors belonging to the MC diffuse midline glioma H3 K27 M mutant and 6 tumors allotted to the MC IDH mutant glioma subclass astrocytoma. Two tumors were classified as MC pilocytic astrocytoma of the posterior fossa, one as MC CNS high grade neuroepithelial tumor with BCOR alteration and one as MC control tissue, inflammatory tumor microenvironment. The methylation profiles of 16 tumors could not clearly be assigned to one distinct MC. In comparison to supratentorial localization, the MC GBM IDH wildtype subclass midline was overrepresented, whereas the MCs GBM IDH wildtype subclass mesenchymal and subclass RTK II were underrepresented in the cerebellum. Based on the integration of molecular and histological findings all tumors received an integrated diagnosis in line with the WHO classification 2016. In conclusion, cGBM does not represent a molecularly uniform tumor entity, but rather comprises different brain tumor entities with diverse prognosis and therapeutic options. Distinction of these molecular tumor classes requires molecular analysis. More than 30% of tumors diagnosed as cGBM belong to the recently described molecular entity of anaplastic astrocytoma with piloid features. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0801-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-10-28 /pmc/articles/PMC6816155/ /pubmed/31661039 http://dx.doi.org/10.1186/s40478-019-0801-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Reinhardt, Annekathrin
Stichel, Damian
Schrimpf, Daniel
Koelsche, Christian
Wefers, Annika K.
Ebrahimi, Azadeh
Sievers, Philipp
Huang, Kristin
Casalini, M. Belén
Fernández-Klett, Francisco
Suwala, Abigail
Weller, Michael
Gramatzki, Dorothee
Felsberg, Joerg
Reifenberger, Guido
Becker, Albert
Hans, Volkmar H.
Prinz, Marco
Staszewski, Ori
Acker, Till
Dohmen, Hildegard
Hartmann, Christian
Paulus, Werner
Heß, Katharina
Brokinkel, Benjamin
Schittenhelm, Jens
Buslei, Rolf
Deckert, Martina
Mawrin, Christian
Hewer, Ekkehard
Pohl, Ute
Jaunmuktane, Zane
Brandner, Sebastian
Unterberg, Andreas
Hänggi, Daniel
Platten, Michael
Pfister, Stefan M.
Wick, Wolfgang
Herold-Mende, Christel
Korshunov, Andrey
Reuss, David E.
Sahm, Felix
Jones, David T. W.
Capper, David
von Deimling, Andreas
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
title Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
title_full Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
title_fullStr Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
title_full_unstemmed Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
title_short Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
title_sort tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816155/
https://www.ncbi.nlm.nih.gov/pubmed/31661039
http://dx.doi.org/10.1186/s40478-019-0801-8
work_keys_str_mv AT reinhardtannekathrin tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT sticheldamian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT schrimpfdaniel tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT koelschechristian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT wefersannikak tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT ebrahimiazadeh tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT sieversphilipp tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT huangkristin tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT casalinimbelen tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT fernandezklettfrancisco tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT suwalaabigail tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT wellermichael tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT gramatzkidorothee tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT felsbergjoerg tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT reifenbergerguido tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT beckeralbert tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT hansvolkmarh tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT prinzmarco tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT staszewskiori tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT ackertill tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT dohmenhildegard tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT hartmannchristian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT pauluswerner tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT heßkatharina tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT brokinkelbenjamin tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT schittenhelmjens tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT busleirolf tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT deckertmartina tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT mawrinchristian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT hewerekkehard tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT pohlute tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT jaunmuktanezane tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT brandnersebastian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT unterbergandreas tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT hanggidaniel tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT plattenmichael tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT pfisterstefanm tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT wickwolfgang tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT heroldmendechristel tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT korshunovandrey tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT reussdavide tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT sahmfelix tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT jonesdavidtw tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT capperdavid tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities
AT vondeimlingandreas tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities